MNM Bioscience
VerifiedOUR MISSION IS TO IDENTIFY THE RIGHT THERAPY FOR EVERY CANCER PATIENT.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$2—3m (Dealroom.co estimates Jan 2020.)
Cambridge Massachusetts (HQ)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 547 % | 179 % | 289 % | 38 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (432 %) | (50 %) | (121 %) | (22 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
$550k | Seed | ||
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about MNM Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.